Q4 2024 Earnings Call Transcript March 13, 2025 Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is ...
Consequently, even though it is one of the closest stars to Earth, such that its light takes only six years to get here, it is too faint to be seen with the naked eye. Now, four small planets have ...
KRRO-110 is the first RNA editing development candidate from Korro's proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...
Q4 2024 Earnings Call Transcript March 13, 2025 Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, ...
Brookfield Renewable Partners offers a 6.5% dividend yield, driven by AI demand and growth trends. Discover BEP’s strong ...